Zealand Pharma A/S and OTR Therapeutics have entered into a strategic collaboration and license agreement aimed at ...

Brian McCollum walks us through Glatt’s capabilities and technologies available at its Ramsey site from development to commercialization.

Eli Lilly and Company plans to invest more than $6 billion in a new manufacturing facility in Huntsville, Alabama.

As drug development grows increasingly complex, pharma and biotech teams are seeking partners with the scientific depth and ...

Medra, a company developing a platform for Physical AI Scientists, has announced a $52 million Series A financing led by ...

The Wellcome Sanger Institute has selected the Sapio Informatics Platform as its central LIMS to underpin the Institute’s lab ...

Tjoapack is expanding its operational footprint in the U.S. with a new 170,000-square-foot facility adjacent to its existing ...

Formycon will develop, register, manufacture, and supply the product, while Zydus will be responsible for commercialization.

Cytiva, a life sciences company, and Fida Biosystems, a Danish company specializing in molecular analysis, have joined forces ...

Advarra has added several new eClinical technologies to its network of partner applications within its Study Collaboration ...

Cellular Origins, a company that enables the manufacturing of cell therapies at scale, has completed a $40 million ...

Charles River Laboratories International Inc. has announced the second cohort of its Cell & Gene Therapy Incubator Program (CIP).